Miyauchi T et al. |
Effect of donor-specific splenocytes via portal vein and FK506 in rat small bowel transplantation. |
1998 |
Transplantation |
pmid:9448139
|
O'Grady J |
C(2) monitoring: out of the blocks but with some way to go! |
2004 |
Transplantation |
pmid:15201659
|
Koprak S et al. |
Depletion of the mature CD4+8- thymocyte subset by FK506 analogs correlates with their immunosuppressive and calcineurin inhibitory activities. |
1996 |
Transplantation |
pmid:8623162
|
Josephson MA et al. |
Calcium and calcitriol prophylaxis attenuates posttransplant bone loss. |
2004 |
Transplantation |
pmid:15502727
|
Yamagami S et al. |
Mechanism of concordant corneal xenograft rejection in mice: synergistic effects of anti-leukocyte function-associated antigen-1 monoclonal antibody and FK506. |
1997 |
Transplantation |
pmid:9233699
|
Johnson MC et al. |
QT prolongation and Torsades de Pointes after administration of FK506. |
1992 |
Transplantation |
pmid:1373538
|
van Hooff JP et al. |
A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients. |
2003 |
Transplantation |
pmid:12829890
|
Stegall MD et al. |
Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus. |
1997 |
Transplantation |
pmid:9422416
|
Donnadieu B et al. |
Central retinal vein occlusion-associated tacrolimus after liver transplantation. |
2014 |
Transplantation |
pmid:25955343
|
Kasahara M et al. |
Living-related liver transplantation for type II citrullinemia using a graft from heterozygote donor. |
2001 |
Transplantation |
pmid:11211185
|
Ovuworie CA et al. |
Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients. |
2001 |
Transplantation |
pmid:11685108
|
Mourad G et al. |
Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. |
2001 |
Transplantation |
pmid:11579299
|
Roy A et al. |
Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant. |
2006 |
Transplantation |
pmid:16926593
|
Vacher-Coponat H et al. |
Tacrolimus/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine. |
2006 |
Transplantation |
pmid:16926601
|
Ciancio G et al. |
Randomized trial of dual antibody induction therapy with steroid avoidance in renal transplantation. |
2011 |
Transplantation |
pmid:22027927
|
Zhao WY et al. |
Single kidneys transplanted from small pediatric donors less than 15 kilograms into pediatric recipients. |
2014 |
Transplantation |
pmid:25955345
|
Mor E et al. |
Late-onset acute rejection in orthotopic liver transplantation--associated risk factors and outcome. |
1992 |
Transplantation |
pmid:1279849
|
Shapiro R et al. |
Posttransplant diabetes in pediatric recipients on tacrolimus. |
1999 |
Transplantation |
pmid:10096540
|
Prud'homme GJ et al. |
GABA protects human islet cells against the deleterious effects of immunosuppressive drugs and exerts immunoinhibitory effects alone. |
2013 |
Transplantation |
pmid:23851932
|
Nashan B et al. |
Clinical validation studies of Neoral C(2) monitoring: a review. |
2002 |
Transplantation |
pmid:12023607
|
Bäckman L et al. |
FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. |
1994 |
Transplantation |
pmid:7509516
|
Tanaka M et al. |
Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation. |
1996 |
Transplantation |
pmid:8830837
|
Franz M et al. |
Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy? |
1998 |
Transplantation |
pmid:9825827
|
Ekberg H et al. |
The challenge of achieving target drug concentrations in clinical trials: experience from the Symphony study. |
2009 |
Transplantation |
pmid:19424036
|
Mestres J et al. |
Late subcapsular lymphocele in a kidney graft. |
2012 |
Transplantation |
pmid:22487814
|
Jain A et al. |
Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus. |
2001 |
Transplantation |
pmid:11374410
|
Cherikh WS et al. |
Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. |
2003 |
Transplantation |
pmid:14627905
|
Singla AK et al. |
Cerulomycin Caerulomycin [corrected] A: a potent novel immunosuppressive agent. |
2014 |
Transplantation |
pmid:24949498
|
Ochiai T et al. |
Optimal serum trough levels of FK506 in renal allotransplantation of the beagle dog. |
1989 |
Transplantation |
pmid:2474208
|
Sommerer C et al. |
Individualized monitoring of nuclear factor of activated T cells-regulated gene expression in FK506-treated kidney transplant recipients. |
2010 |
Transplantation |
pmid:20463649
|
Walsh C et al. |
Anti-CD25 monoclonal antibody replacement therapy for chronic kidney disease in liver transplant recipients. |
2013 |
Transplantation |
pmid:23296149
|
Froud T et al. |
Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes. |
2008 |
Transplantation |
pmid:19104407
|
Muraki T et al. |
Antithrombotic effect of FK506 versus prothrombotic effect of cyclosporine in vivo. |
1995 |
Transplantation |
pmid:7544038
|
Yamani MH et al. |
The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection. |
2000 |
Transplantation |
pmid:10868634
|
Verleden GM et al. |
Successful conversion from cyclosporine to tacrolimus for gastric motor dysfunction in a lung transplant recipient. |
2002 |
Transplantation |
pmid:12131703
|
Johnson C et al. |
Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation. |
2000 |
Transplantation |
pmid:10755536
|
Ekser B et al. |
Hepatic function after genetically engineered pig liver transplantation in baboons. |
2010 |
Transplantation |
pmid:20606605
|
Alloway R et al. |
Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients. |
2007 |
Transplantation |
pmid:17589351
|
Uchikoshi F et al. |
Restoration of immune abnormalities in diabetic BB rats after pancreas transplantation. I. Macrochimerism of donor-graft-derived RT6+ T cells responsible for restoration of immune responsiveness and suppression of autoimmune reaction. |
1996 |
Transplantation |
pmid:8669109
|
Dieterle CD et al. |
Glucose metabolism after pancreas transplantation: cyclosporine versus tacrolimus. |
2004 |
Transplantation |
pmid:15239622
|
Tian L et al. |
Association of the CD134/CD134L costimulatory pathway with acute rejection of small bowel allograft. |
2002 |
Transplantation |
pmid:12134113
|
Meiser BM and Reichart B |
New trends in clinical immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7527954
|
Nakajima K et al. |
Effects of triple therapy of cyclosporine, FK 506, and RS-61443 on allogeneic small bowel transplantation in dogs. |
1993 |
Transplant. Proc. |
pmid:7679821
|
Ohtsuka S et al. |
Hamster-to-rat xenotransplantation of whole pancreas by FK 506 combined with splenectomy. |
1994 |
Transplant. Proc. |
pmid:7513473
|
Risaliti A et al. |
Cardiovascular and metabolic complications after liver transplantation: Neoral- versus tacrolimus-based immunosuppression. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750569
|
Goto T et al. |
FK 506: historical perspectives. |
1991 |
Transplant. Proc. |
pmid:1721254
|
Ciancio G et al. |
Current advantage of FK 506 in cadaveric kidney transplantation. |
1996 |
Transplant. Proc. |
pmid:8623207
|
Vanrenterghem Y et al. |
Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. |
1998 |
Transplant. Proc. |
pmid:9636523
|
Tanabe K et al. |
Japanese single-center experience of kidney transplantation under tacrolimus immunosuppression. |
2000 |
Transplant. Proc. |
pmid:11119897
|
Bruce DS et al. |
Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9532150
|
Gutiérrez Sánchez MJ et al. |
Optimization of immunosuppression by switching from azathioprine to enteric-coated mycophenolate sodium in stable kidney transplant patients. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715907
|
Rafecas A et al. |
Immunosuppression with calcineurin inhibitors and polyclonal antibodies in liver transplantation. |
2002 |
Transplant. Proc. |
pmid:11959209
|
Aptaramanov B et al. |
A comparison of mycophenolate mofetil with mycophenolate sodium in renal transplant recipients on tacrolimus-based treatment. |
2011 |
Transplant. Proc. |
pmid:21486609
|
Ma A et al. |
Immunological evaluation of combination therapy with tacrolimus and sirolimus on long-term allograft survival in nonhuman primates. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808578
|
Francavilla A et al. |
FK 506 as a growth control factor. |
1990 |
Transplant. Proc. |
pmid:1689912
|
Soriano S et al. |
Single-center experience with initial intravenous dosing of tacrolimus after kidney transplantation. |
1999 |
Transplant. Proc. |
pmid:10576045
|
Serrano M et al. |
Clinical value of a single determination of intracellular ATP levels in stimulated CD4+ T lymphocytes in pediatric patients with stable liver transplantation. |
2012 |
Transplant. Proc. |
pmid:23146475
|
Liu M et al. |
C4d-positive acute humoral renal allograft rejection: rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil. |
2004 |
Transplant. Proc. |
pmid:15518760
|
Hayashi S et al. |
Synergistic effect of donor pretreatment using FK 506 in hamster-to-rat cardiac xenotransplantation. |
1994 |
Transplant. Proc. |
pmid:7518126
|
Woodle ES et al. |
Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection. |
1993 |
Transplant. Proc. |
pmid:7682358
|
Senninger N et al. |
Glucose metabolism following liver transplantation and immunosuppression with cyclosporine A or FK 506. |
1995 |
Transplant. Proc. |
pmid:7533364
|
Yagihashi A et al. |
The effect of FK 506 on peripheral blood T-lymphocyte subsets in orthotopic liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721318
|
Ziolkowski J et al. |
Effect of immunosuppressive regimen on acute rejection and liver graft function. |
2003 |
Transplant. Proc. |
pmid:14529915
|
Kato T et al. |
FK506 may suppress liver injury during the early period following living-related liver transplantation. |
2003 |
Transplant. Proc. |
pmid:12591316
|
Ã…berg F et al. |
Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report. |
2015 |
Transplant. Proc. |
pmid:26680092
|
Braun F et al. |
Therapeutic drug monitoring of tacrolimus early after liver transplantation. |
2002 |
Transplant. Proc. |
pmid:12176473
|
Tashiro H et al. |
Monitoring for engraftment of rat orthotopic liver transplantation by semiquantitative PCR. |
1995 |
Transplant. Proc. |
pmid:7533421
|
Schorlemmer HU et al. |
Long-term allograft survival and tolerance induction by the synergistic activity of malononitrilamides and tacrolimus. |
1998 |
Transplant. Proc. |
pmid:9865312
|
Felser I et al. |
Changes in quality of life following conversion from CyA to FK 506 in orthotopic liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721350
|
Chiereghin A et al. |
Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172283
|
Nanni G et al. |
Lack of correlation between serum levels of mycophenolate mofetil and kidney transplant outcome in tacrolimus-based immunosupression. |
2002 |
Transplant. Proc. |
pmid:12270323
|
Chmiel B et al. |
Rheological properties of red blood cells in kidney transplant recipients: the role of lipid profile and type of immunosuppresion. |
2005 |
Transplant. Proc. |
pmid:15919493
|
Walgenbach KJ et al. |
Increased presence of mast cells and interleukin-4 during chronic rejection of rat intestinal allografts. |
1996 |
Transplant. Proc. |
pmid:8907896
|
Miyagi M et al. |
Comparison of the therapeutic effects between CsA and FK506 on chronic renal allograft injury and TGF-beta expression. |
2002 |
Transplant. Proc. |
pmid:12176497
|
Malaise J et al. |
Immunosuppressive drugs after simultaneous pancreas-kidney transplantation. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182827
|
Zmonarski SC et al. |
Lowering of Messenger Ribonucleic Acid Toll-Like Receptors 2-4,9 in Peripheral Blood Mononuclear Cells in Kidney Allograft Recipients, Relationships With Immunosuppressive Treatment, and Delayed Graft Function Occurrence. |
2016 |
Transplant. Proc. |
pmid:27496439
|
Oishi M et al. |
Successful swine small bowel transplantation using FK506: effect on endotoxin translocation. |
1994 |
Transplant. Proc. |
pmid:7520629
|
Moutabarrik A et al. |
FK 506 mechanism of nephrotoxicity: stimulatory effect on endothelin secretion by cultured kidney cells and tubular cell toxicity in vitro. |
1991 |
Transplant. Proc. |
pmid:1721382
|
Han DJ et al. |
A 39-month follow-up study to evaluate the safety and efficacy in kidney transplant recipients treated with modified-release tacrolimus (FK506E)-based immunosuppression regimen. |
2012 |
Transplant. Proc. |
pmid:22310592
|
Chang HR et al. |
Lack of hepatotoxicity upon sirolimus addition to a calcineurin inhibitor-based regimen in hepatitis virus-positive renal transplant recipients. |
2007 |
Transplant. Proc. |
pmid:17580178
|
Jiang H et al. |
IL-10: a tacrolimus-specific cytotoxic mediator in ongoing allograft rejection. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11266931
|
Ohtsuka S et al. |
The effect of short-term FK 506 therapy on pancreas transplantation in rats. |
1991 |
Transplant. Proc. |
pmid:1721413
|
Tanabe K et al. |
Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8658670
|
Cirocco RE et al. |
Kidney recipient CMV incidence in the gancyclovir era: monitoring viral DNA by a CMV-PCR assay. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083604
|
Nakao A et al. |
Cytokine mRNA expression on rat small bowel allograft treated with tacrolimus and simultaneous bone marrow transplantation via the portal vein. |
2000 |
Transplant. Proc. |
pmid:10995965
|
Soltero L et al. |
Coadministration of tacrolimus and ketoconazole in renal transplant recipients: cost analysis and review of metabolic effects. |
2003 |
Transplant. Proc. |
pmid:12826147
|
Levy GA |
Neoral is superior to FK 506 in liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9723293
|
Glanemann M et al. |
Higher immunosuppressive efficacy of mycophenolate mofetil in combination with FK 506 than in combination with cyclosporine A. |
2000 |
Transplant. Proc. |
pmid:10812095
|
Fábrega E et al. |
Effect of immunosuppressant blood levels on serum concentration of interleukin-17 and -23 in stable liver transplant recipients. |
2009 |
Transplant. Proc. |
pmid:19376417
|
Burke GW et al. |
Steroid-resistant acute rejection following SPK: importance of maintaining therapeutic dosing in a triple-drug regimen. |
2002 |
Transplant. Proc. |
pmid:12176628
|
Moura Neto A et al. |
Clinical Profile of Patients With Diabetes Mellitus and Liver Transplantation: Results After a Multidisciplinary Team Intervention. |
2018 |
Transplant. Proc. |
pmid:29661438
|
Duzova A et al. |
Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year. |
2003 |
Transplant. Proc. |
pmid:14697926
|
Morales E et al. |
Conversion from cyclosporine to FK 506 as rescue therapy in renal transplantation with poorly steroid-responsive acute rejection. |
1999 |
Transplant. Proc. |
pmid:10500562
|
Nardo B et al. |
Evidence of microchimerism after pretransplant blood transfusion and FK 506 in liver xenograft. |
2000 |
Transplant. Proc. |
pmid:11134771
|
Miyata Y et al. |
Development of xenogeneic microchimerism correlated with graft outcome in hamster-to-rat heart xenotransplantation. |
1998 |
Transplant. Proc. |
pmid:9723548
|
Chamienia A et al. |
Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results. |
2014 |
Transplant. Proc. |
pmid:25380901
|
Kocak H et al. |
Tacrolimus plus low-dose mycophenolate mofetil in renal transplant recipients: better 2-year graft and patient survival than with a higher mycophenolate mofetil dose. |
2005 |
Transplant. Proc. |
pmid:16213288
|
Reimer J et al. |
Quality of life after kidney transplantation--the impact of tacrolimus. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267573
|
McLaughlin GE et al. |
Effect of aminophylline on urine flow in children with tacrolimus-induced renal insufficiency. |
2000 |
Transplant. Proc. |
pmid:10856596
|
Fritsche L et al. |
Conversion to mycophenolate mofetil for chronic progressive deterioration of renal allograft function: first clinical experiences in 44 patients. |
1998 |
Transplant. Proc. |
pmid:9636481
|